Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology

Gerhard Walzl, Sabrina Tafuro, Paul Moss, Peter J M Openshaw, Tracy Hussell

    Research output: Contribution to journalArticlepeer-review

    Abstract

    The effect of infection history is ignored in most animal models of infectious disease. The attachment protein of respiratory syncytial virus (RSV) induces T helper cell type 2-driven pulmonary eosinophilia in mice similar to that seen in the failed infant vaccinations in the 1960s. We show that previous influenza virus infection of mice: (a) protects against weight loss, illness, and lung eosinophilia; (b) attenuates recruitment of inflammatory cells; and (c) reduces cytokine secretion caused by RSV attachment protein without affecting RSV clearance. This protective effect can be transferred via influenza-immune splenocytes to naive mice and is long lived. Previous immunity to lung infection clearly plays an important and underestimated role in subsequent vaccination and infection. The data have important implications for the timing of vaccinations in certain patient groups, and may contribute to variability in disease susceptibility observed in humans.
    Original languageEnglish
    Pages (from-to)1317-1326
    Number of pages9
    JournalJournal of Experimental Medicine
    Volume192
    Issue number9
    DOIs
    Publication statusPublished - 6 Nov 2000

    Keywords

    • Complex tetramers
    • Eosinophils
    • Major histocompatibility
    • Mucosal immunology
    • Murine model
    • Viral immunology

    Fingerprint

    Dive into the research topics of 'Influenza virus lung infection protects from respiratory syncytial virus-induced immunopathology'. Together they form a unique fingerprint.

    Cite this